Minireviews
Copyright ©The Author(s) 2021.
World J Gastroenterol. Jul 7, 2021; 27(25): 3837-3850
Published online Jul 7, 2021. doi: 10.3748/wjg.v27.i25.3837
Table 1 Association between gut microbiomes and obesity
Microbiota characteristics in obesity
Preclinical or clinical
Study subjects
Ref.
Firmicutes/Bacteroidetes ratio increasedPreclinicalMiceLey et al[20], Turnbaugh et al[21]
ClinicalChildhoodIndiani et al[22]
ClinicalAdult ukrainian populationKoliada et al[23]
The relative abundance of Christensenellaceae was inversely related to host BMIClinicalHumanWaters et al[26]
ClinicalPostmenopausal womenAlemán et al[33]
ClinicalItalian elderlyTavella et al[36]
Increased Akkermansia population reduced body weightClinicalHumanDepommier et al[27]
PreclinicalMiceAnhê et al[34]
Lactobacillus paracasei decreased, while Lactobacillus reuteri and Lactobacillus gasseri increasedClinicalHumanCrovesy et al[28], Million et al[31]
Bifidobacteria reducedPreclinicalRatsWaldram et al[30]
Methanobacteriales smithii and Bifidobacterium were associated with normal weightClinicalHumanMillion et al[31]
Table 2 Mechanism of obesity induced by gut microbiota
Effect
Microbiota characteristics
Mechanism
Ref.
Increased energy absorptionExpansion of Desulfovibrio and loss of ClostridiaElevated the expression of genes that control lipid absorption such as CD36Petersen et al[44]
Extra energy for the hostThe inverse association between fecal SCFAs and gut microbiota diversity; Faecalibacterium prausnitzii, Roseburia faecis, and other Clostridiales increased; Akkermansia muciniphila, Alistipes finegoldii, Bacteroides, Christensenellaceae, Methanobrevibacter, and Oscillospira decreasedExcessive SCFAsde la Cuesta-Zuluaga et al[49]
Increased appetiteA community dominated by members of the Clostridial clusters XIVa and IVThe levels of peptide YY and GLP-1 in obese patients decrease significantlyWu et al[54], Salehi et al[55], Federico et al[56]
Decreased Fat storageGerm free mice colonized with Lactobacillus paracaseiIncrease the expression of ANGPTL4, and inhibit LPL, leading to decreased fat storageAronsson et al[59], Tazi et al[60]
Increased fat storageTransplanting gut microbes from conventionally raised mice into germ-free miceIncreasing the expression of ChREBP and SREBP-1, Fiaf is inhibited, activate LPL, help triglycerides enter the circulatory system from the liverBäckhed et al[19]
Decreased chronic inflammationIncrease levels in the butyrate-producing bacteria such as Ruminococcaceae and LachnospiraceaeInhibit pathways leading to the production of pro-inflammatory cytokines; Stimulate adipoliolysis and mitochondrial oxidative phosphorylation, thereby achieving greater energy consumption; Reduce LPS, thereby reducing chronic low-grade inflammationKang et al[66], Lührs et al[67], Jia et al[68]
Interruption of circadian rhythmBile salts biotransformation bacteria such as Lachnospiraceae, Clostridiaceae, Ruminococcaceae, Lactobacillus, Bacteroides, and BifidobacteriumRegulate transcription of key genes involved in circadian rhythm (Dbp, Per1/2) and lipid metabolism (Pparγ, Angptl4)Joyce et al[77], Parkar et al[78]